A Prospective, Multi-center, Single-arm, Interventional Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant in China

Trial Profile

A Prospective, Multi-center, Single-arm, Interventional Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant in China

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Methylprednisolone; Mycophenolate mofetil; Mycophenolate sodium; Prednisone; Tacrolimus
  • Indications Transplant rejection
  • Focus Therapeutic Use
  • Acronyms START-DCD
  • Sponsors Sanofi
  • Most Recent Events

    • 12 Sep 2017 Planned End Date changed from 16 Aug 2019 to 31 Jul 2020.
    • 12 Sep 2017 Planned primary completion date changed from 16 Aug 2019 to 31 Jul 2020.
    • 12 Sep 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top